← Back to search
8tt9

X-ray structure of Macrophage Migration Inhibitory Factor (MIF) Covalently Bound to 4-hydroxyphenylpyruvate (HPP)

Method: X-RAY DIFFRACTION Dmax: 59.6 Å Quality: GOOD
▼

1. Protein Identity and Related Structures Protein Identity & Related Structures

Macrophage migration inhibitory factor

Homo sapiens

UniProt P14174

State in the Current Structure

Assembly Oligomeric State Construct Mutations and Modifications Ligands, Ions and Associated Components Method and Experimental Conditions Structure Quality
1 Protein homooligomer Homooligomer Protein × 3 PDB declaration: trimeric（3） Consistent with protein copy count Chain A； UniProt 2–115 Chain B； UniProt 2–115 Chain C； UniProt 2–115 Not recorded ENO 3-(4-HYDROXY-PHENYL)PYRUVIC ACID × 3 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION X-ray crystallization conditions：VAPOR DIFFUSION, SITTING DROP；pH 7.5；293 K；2M AMMONIUM SULFATE, 4% ISOPROPANOL, 0.1 M TRIS(HYDROXYMETHYL)AMINOMETHAN; MIXED WITH PROTEIN:INHIBITOR COMPLEX IN A 1:10 RATIO Resolution 1.68 Å R-free 0.199

Other States of the Same Protein in the Database

Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.

Other PDB Difference from Current Entry 8TT9 Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Method and Experimental Conditions Structure Quality
1CA7 MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH HYDROXPHENYLPYRUVATE Deposited 1999-02-25 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded EN1 (2E)-2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8；pH 8.0
Resolution 2.50 Å R-free 0.263
1CGQ MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH ALANINE INSERTED BETWEEN PRO-1 AND MET-2 Deposited 1999-03-25 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：INS(A-M2) Mutation：INS(A-M2) Mutation：INS(A-M2) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；pH 7.5
Resolution 2.00 Å R-free 0.275
1GCZ MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) COMPLEXED WITH INHIBITOR. Deposited 2000-08-24 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 10 CIT CITRIC ACID × 3 YZ9 7-HYDROXY-2-OXO-CHROMENE-3-CARBOXYLIC ACID ETHYL ESTER × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5；298 K；ammonium sulfate, sodium citrate, pH 5.0, vapor diffusion/hanging drop, temperature 298.0K
Resolution 1.90 Å R-free 0.240
1GD0 HUMAN MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) Deposited 2000-08-24 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 7 CIT CITRIC ACID × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5；298 K；ammonium sulfate, sodium citrate, pH 5.0, vapor diffusion : hanging drop, temperature 298.0K
Resolution 1.50 Å R-free 0.214
1GIF HUMAN GLYCOSYLATION-INHIBITING FACTOR Deposited 1996-02-27 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–114（114 aa）
Chain B 1–114（114 aa）
Chain C 1–114（114 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 1.90 Å
1LJT Crystal Structure of Macrophage Migration Inhibitory Factor complexed with (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole-acetic acid methyl ester (ISO-1) Deposited 2002-04-22 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–114（114 aa）
Chain B 1–114（114 aa）
Chain C 1–114（114 aa）
Not recorded HDI 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；298 K；ammonium sulfate, isopropanol, Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.00 Å R-free 0.262
1MIF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) Deposited 1996-01-26 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–115（115 aa）
Chain B 1–115（115 aa）
Chain C 1–115（115 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.60 Å
1P1G MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH PRO-1 MUTATED TO GLY-1 Deposited 1999-03-24 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：P1G Mutation：P1G Mutation：P1G No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；pH 7.5
Resolution 2.50 Å R-free 0.270
2OOH Crystal Structure of MIF bound to a Novel Inhibitor, OXIM-11 Deposited 2007-01-25 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–114（114 aa）
Chain B 1–114（114 aa）
Chain C 1–114（114 aa）
Not recorded SO4 SULFATE ION × 8 OX3 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；296 K；50% saturated ammonium sulfate, 4% isopropanol, 0.1 M tris(hydroxymethyl)aminomethane,mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K
Resolution 1.85 Å R-free 0.218
2OOW MIF Bound to a Fluorinated OXIM Derivative Deposited 2007-01-26 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–114（114 aa）
Chain B 1–114（114 aa）
Chain C 1–114（114 aa）
Not recorded SO4 SULFATE ION × 5 OX4 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME × 2 GOL GLYCEROL × 6 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；296 K；50% saturated ammonium sulfate, 4% isopropanol, 0.1 M tris(hydroxymethyl)aminomethan; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K
Resolution 1.75 Å R-free 0.204
2OOZ Macrophage Migration Inhibitory Factor (MIF) Complexed with OXIM6 (an OXIM Derivative Not Containing a Ring in its R-group) Deposited 2007-01-26 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–114（114 aa）
Chain B 1–114（114 aa）
Chain C 1–114（114 aa）
Not recorded SO4 SULFATE ION × 5 OX5 4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME × 2 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；296 K；50% saturated ammonium sulfate, 4% isopropanol, 0.1 M tris(hydroxymethyl)aminomethan; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K
Resolution 1.80 Å R-free 0.225
3B9S Macrophage Migration Inhibitory Factor (MIF) complexed with Inhibitor, 4-IPP. Deposited 2007-11-06 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded GOL GLYCEROL × 3 RW1 4-phenylpyrimidine × 3 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2M ammonium sulfate, 4% isopropanol, 0.1 M tris(hydroxymethyl)aminomethan; mixed with protein:inhibitor complex in a 1:10 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.80 Å R-free 0.230
3CE4 Structure of Macrophage Migration Inhibitory Factor Covalently Inhibited by PMSF Treatment Deposited 2008-02-28 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 5 PMF PHENYLMETHYLSULFONYL FLUORIDE × 3 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；293 K；50% saturated ammonium sulfate, 4% isopropanol, 0.1M tris(hydroxymethyl)aminomethane; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.55 Å R-free 0.209
3DJH Macrophage Migration Inhibitory Factor (MIF) at 1.25 A Resolution Deposited 2008-06-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 6 GOL GLYCEROL × 4 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；50% Saturated ammonium sulfate, 3% Isopropanol, 0.1 M Tris(hydroxymethyl)aminomethane, mixed with protein in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 1.25 Å R-free 0.186
3DJI Crystal Structure of Macrophage Migration Inhibitory Factor Bound to an Acetaminophen Dimer Derived from NAPQI Deposited 2008-06-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 9 3E1 N,N'-(6,6'-dihydroxybiphenyl-3,3'-diyl)diacetamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；2 M Ammonium sulfate, 3% Isopropanol, 0.1 M Tris(hydroxymethyl)aminomethane, mixed with protein-inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 1.95 Å R-free 0.247
3DJI Crystal Structure of Macrophage Migration Inhibitory Factor Bound to an Acetaminophen Dimer Derived from NAPQI Deposited 2008-06-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain D 2–115（114 aa）
Chain E 2–115（114 aa）
Chain F 2–115（114 aa）
Not recorded CL CHLORIDE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；2 M Ammonium sulfate, 3% Isopropanol, 0.1 M Tris(hydroxymethyl)aminomethane, mixed with protein-inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K
Resolution 1.95 Å R-free 0.247
3HOF Structure of macrophage migration inhibitory factor (MIF) with caffeic acid at 1.9A resolution Deposited 2009-06-02 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–115（115 aa）
Chain B 1–115（115 aa）
Chain C 1–115（115 aa）
Not recorded DHC CAFFEIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；296 K；30-42.5% MPD_P1K_P3350 mix (MDL Morpheus screen), 0.1M buffer 1 mix (MDL morpheus screen), pH 5.5-7.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K
Resolution 1.90 Å R-free 0.200
3IJG Macrophage Migration Inhibitory Factor (MIF) Bound to the (R)-Stereoisomer of AV1013 Deposited 2009-08-04 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 10 AVR (2R)-2-amino-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；310 K；2 M ammonium sulfate, 3% isopropanol, 0.5 M NaCl, 0.1 M tris(hydroxymethyl)aminomethane; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 310K
Resolution 1.70 Å R-free 0.206
3IJJ Ternary Complex of Macrophage Migration Inhibitory Factor (MIF) Bound Both to 4-hydroxyphenylpyruvate and to the Allosteric Inhibitor AV1013 (R-stereoisomer) Deposited 2009-08-04 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded EN1 (2E)-2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid × 3 ENO 3-(4-HYDROXY-PHENYL)PYRUVIC ACID × 3 CL CHLORIDE ION × 8 AVR (2R)-2-amino-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；310 K；2 M ammonium sulfate, 3% isopropanol, 0.5 M NaCl, 0.1 M tris(hydroxymethyl)aminomethane; mixed in a 1:1 ratio with the protein:substrate:inhibitor complex, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 310K
Resolution 1.25 Å R-free 0.185
3JSF Crystal structure of macrophage migration inhibitory factor (mif) with hydroxyquinoline inhibitor 638 at 1.93a resolution Deposited 2009-09-10 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded XV1 7-(2-fluorobenzyl)quinolin-8-ol × 3 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；1.5 M AMMONIUM SULFATE, 2 mM EDTA, 0.1 M HEPES, PH 6.5, VAPOR DIFFUSION/HANGING DROP, TEMPERATURE 298.0K , VAPOR DIFFUSION, HANGING DROP
Resolution 1.93 Å R-free 0.218
3JSG Crystal structure of macrophage migration inhibitory factor (mif) with hydroxyquinoline inhibitor 707 at 1.58a resolution Deposited 2009-09-10 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 0IN 7-(pyridin-3-ylmethyl)quinolin-8-ol × 3 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；1.5 M AMMONIUM SULFATE, 2 mM EDTA, 0.1 M HEPES, PH 6.5, VAPOR DIFFUSION/HANGING DROP, TEMPERATURE 298.0K , VAPOR DIFFUSION, HANGING DROP
Resolution 1.58 Å R-free 0.201
3JTU Crystal structure of macrophage migration inhibitory factor (mif) with hydroxyquinoline inhibitor 708 at 1.86a resolution Deposited 2009-09-14 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded ZIN 7-(pyridin-2-ylmethyl)quinolin-8-ol × 3 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；1.5 M AMMONIUM SULFATE, 2 mM EDTA, 0.1 M HEPES, PH 6.5, VAPOR DIFFUSION/HANGING DROP, , VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.86 Å R-free 0.192
3L5P Crystal structure of macrophage migration inhibitory factor (MIF) with imidazopyridazinol inhibitor at 1.80A resolution Deposited 2009-12-22 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 428 2-(1-methylethyl)imidazo[1,2-b]pyridazin-6-ol × 1 GOL GLYCEROL × 3 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；0.6 M AMMONIUM SULFATE, 0.1 M HEPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.80 Å R-free 0.221
3L5R Crystal structure of macrophage migration inhibitory factor (MIF) with phenylchromenone inhibitor at 1.94A resolution Deposited 2009-12-22 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 47X 3-(3,4-dihydroxyphenyl)-7-hydroxy-4H-chromen-4-one × 1 SO4 SULFATE ION × 5 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；0.6 M AMMONIUM SULFATE, 0.1 M HEPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.94 Å R-free 0.233
3L5S Crystal structure of macrophage migration inhibitory factor (MIF) with imidazopyrimidinylphenyl inhibitor at 1.86A resolution Deposited 2009-12-22 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 88X 5-ethyl-2-(phenylcarbonyl)imidazo[1,2-a]pyrimidin-7(1H)-one × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；0.6 M AMMONIUM SULFATE, 0.1 M HEPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.86 Å R-free 0.201
3L5T Crystal structure of macrophage migration inhibitory factor (MIF) with thiophenepiperazinylquinolinone inhibitor at 1.86A resolution Deposited 2009-12-22 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 956 1-methyl-2-oxo-4-[4-(thiophen-2-ylcarbonyl)piperazin-1-yl]-1,2-dihydroquinoline-3-carbonitrile × 1 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；0.6 M AMMONIUM SULFATE, 0.1 M HEPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.86 Å R-free 0.214
3L5U Crystal structure of macrophage migration inhibitory factor (MIF) with benzothiazole inhibitor at 1.90A resolution Deposited 2009-12-22 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded ZEC 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE × 3 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；0.6 M AMMONIUM SULFATE, 0.1 M HEPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.90 Å R-free 0.209
3L5V Crystal structure of macrophage migration inhibitory factor (MIF) with glycerol at 1.70A resolution Deposited 2009-12-22 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded GOL GLYCEROL × 3 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；0.6 M AMMONIUM SULFATE, 0.1 M HEPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.70 Å R-free 0.211
3SMB Phenethylisothiocyanate Covalently Bound to Macrophage Migration Inhibitory Factor (MIF) Deposited 2011-06-27 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded LE2 N-(2-phenylethyl)thioformamide × 3 CL CHLORIDE ION × 9 NA SODIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% isopropanol, 0.1 M tris(hydroxymethyl)aminomethane; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.60 Å R-free 0.197
3SMC Macrophage Migration Inhibitory Factor (MIF) with Covalently Bound L-sulforaphane Deposited 2011-06-27 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded LE3 N-{4-[(R)-methylsulfinyl]butyl}thioformamide × 3 CL CHLORIDE ION × 7 NA SODIUM ION × 4 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% isopropanol, 0.1 M tris(hydroxymethyl)aminomethane; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.80 Å R-free 0.186
3U18 Chicago Sky Blue 6B, A Novel Inhibitor for Macrophage Migration Inhibitory Factor Deposited 2011-09-29 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded Y0X 6,6'-[(3,3'-dimethoxybiphenyl-4,4'-diyl)di(E)diazene-2,1-diyl]bis(4-amino-5-hydroxynaphthalene-1,3-disulfonic acid) × 1 IPA ISOPROPYL ALCOHOL × 4 GOL GLYCEROL × 9 EDO 1,2-ETHANEDIOL × 3 NA SODIUM ION × 4 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 8；310 K；100 mM p425 dissolved in 2.0 M ammonium sulfate, 4% 2-propanol, 0.1 M Tris, VAPOR DIFFUSION, temperature 310K, pH 8
Resolution 1.90 Å R-free 0.177
3WNR Multiple binding modes of benzyl isothiocyanate inhibitor complexed with Macrophage Migration Inhibitory Factor Deposited 2013-12-16 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 9BE N-benzylthioformamide × 3 SO4 SULFATE ION × 5 GOL GLYCEROL × 5 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；1.9M ammonium sulfate, 100mM Tris pH 8.0, 200mM NaCl, 4%(v/v) 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.01 Å R-free 0.200
3WNS Allyl isothiocyanate inhibitor complexed with Macrophage Migration Inhibitory Factor Deposited 2013-12-16 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 9AI N-prop-2-en-1-ylthioformamide × 3 SO4 SULFATE ION × 6 IPA ISOPROPYL ALCOHOL × 1 CL CHLORIDE ION × 1 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；1.9M ammonium sulfate, 100mM Tris pH 8.0, 200mM NaCl, 4%(v/v) 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.66 Å R-free 0.258
3WNT Multiple binding modes of benzyl isothiocyanate inhibitor complexed with Macrophage Migration Inhibitory Factor Deposited 2013-12-16 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 9BE N-benzylthioformamide × 3 SO4 SULFATE ION × 5 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；1.9M ammonium sulfate, 100mM Tris pH 8.0, 200mM NaCl, 4%(v/v) 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.07 Å R-free 0.263
4ETG Crystal Structure of MIF L46G mutant Deposited 2012-04-24 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：L46G Mutation：L46G Mutation：L46G SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 7.5；291 K；1.8M Ammonium sulfate in 0.1M Tris and 3% isopropanol, pH 7.5, VAPOR DIFFUSION, temperature 291K
Resolution 1.61 Å R-free 0.249
4EUI Crystal Structure of MIF L46F mutant Deposited 2012-04-25 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：L46F Mutation：L46F Mutation：L46F SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 7.5；291 K；1.8M Ammonium sulfate in 0.1M Tris and 3% isopropanol, pH 7.5, VAPOR DIFFUSION, temperature 291K
Resolution 1.70 Å R-free 0.259
4EVG Crystal Structure of MIF L46A mutant Deposited 2012-04-26 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：L46A Mutation：L46A Mutation：L46A SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION；pH 7.5；291 K；1.8M Ammonium sulfate in 0.1M Tris (pH 7.5) and 3% isopropanol, VAPOR DIFFUSION, temperature 291K
Resolution 1.70 Å R-free 0.214
4F2K Macrophage Migration Inhibitory Factor covalently complexed with phenethylisothiocyanate Deposited 2012-05-08 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded LE2 N-(2-phenylethyl)thioformamide × 3 SO4 SULFATE ION × 4 IPA ISOPROPYL ALCOHOL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；298 K；1.9M (NH4)2SO4, 100mM Tris pH 8.0, 200mM NaCl, 4% v/v isopropanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.53 Å R-free 0.228
4GRN crystal structure of PAAM mutant of human MIF Deposited 2012-08-26 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 12 SO4 SULFATE ION × 4 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；2M NH42SO4, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.25 Å R-free 0.141
4GRO Crystallographic and biological characterization of N- and C- terminus mutants of human MIF Deposited 2012-08-26 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Mutation：Pro1-Ala2 are insertions No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；2.0 ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.230
4GRO Crystallographic and biological characterization of N- and C- terminus mutants of human MIF Deposited 2012-08-26 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Chain D 2–115（114 aa）
Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；2.0 ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.230
4GRO Crystallographic and biological characterization of N- and C- terminus mutants of human MIF Deposited 2012-08-26 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain E 2–115（114 aa）
Chain F 2–115（114 aa）
Chain H 2–115（114 aa）
Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions CL CHLORIDE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；2.0 ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.230
4GRO Crystallographic and biological characterization of N- and C- terminus mutants of human MIF Deposited 2012-08-26 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain G 2–115（114 aa）
Mutation：Pro1-Ala2 are insertions CL CHLORIDE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；2.0 ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.00 Å R-free 0.230
4GRP Crystallographic and biological characterization of N- and C- terminus mutants of human MIF Deposited 2012-08-26 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions SO4 SULFATE ION × 5 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6；293 K；1.6M ammonium sulfate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.27 Å R-free 0.169
4GRQ Characterization of N- and C- terminus mutants of human MIF Deposited 2012-08-26 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions CL CHLORIDE ION × 6 SO4 SULFATE ION × 1 AVL 2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5；310 K；1.6M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 310K
Resolution 1.65 Å R-free 0.161
4GRR characterization of N- and C- terminus mutants of human MIF Deposited 2012-08-26 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 3–115（113 aa）
Chain B 3–115（113 aa）
Chain C 3–115（113 aa）
Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions SO4 SULFATE ION × 5 CL CHLORIDE ION × 11 AVR (2R)-2-amino-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；310 K；1.6M ammmonium sualfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 310K
Resolution 1.47 Å R-free 0.172
4GRU crystallographic and biological characterization of N- and C- terminus mutants of human MIF Deposited 2012-08-26 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions Mutation：Pro1-Ala2 are insertions CL CHLORIDE ION × 12 DIO 1,4-DIETHYLENE DIOXIDE × 3 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；2.0M ammonium sulfate, pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.92 Å R-free 0.230
4GUM Cystal structure of locked-trimer of human MIF Deposited 2012-08-29 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：N110C Mutation：N110C Mutation：N110C CL CHLORIDE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8；293 K；0.2M LiSO4, 3% DMSO, pH8.0, 33% PEG4000 , VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.33 Å R-free 0.272
4GUM Cystal structure of locked-trimer of human MIF Deposited 2012-08-29 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain D 2–115（114 aa）
Chain E 2–115（114 aa）
Chain F 2–115（114 aa）
Mutation：N110C Mutation：N110C Mutation：N110C CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8；293 K；0.2M LiSO4, 3% DMSO, pH8.0, 33% PEG4000 , VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.33 Å R-free 0.272
4GUM Cystal structure of locked-trimer of human MIF Deposited 2012-08-29 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain G 2–115（114 aa）
Chain H 2–115（114 aa）
Chain I 2–115（114 aa）
Mutation：N110C Mutation：N110C Mutation：N110C CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8；293 K；0.2M LiSO4, 3% DMSO, pH8.0, 33% PEG4000 , VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.33 Å R-free 0.272
4K9G 1.55 A Crystal Structure of Macrophage Migration Inhibitory Factor bound to ISO-66 and a related compound Deposited 2013-04-19 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 1Q2 (4R,6Z)-6-(3-fluoro-4-hydroxyphenyl)-4-hydroxy-6-iminohexan-2-one × 3 1Q1 1-[(5S)-3-(3-fluoro-4-hydroxyphenyl)-4,5-dihydro-1,2-oxazol-5-yl]propan-2-one × 1 CL CHLORIDE ION × 6 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；293 K；1.1 mM (14 mg/ml) MIF , 10 mM inhibitor in 10% DMSO, 18 mM NaCl, 18 mM tris(hydroxymethyl)aminomethane mixed 1:1 with reservoir containing 2 M ammonium sulfate, 0.1 M tris(hydroxymethyl)aminomethane, 3% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.55 Å R-free 0.220
4OSF 4-(2-isothiocyanatoethyl)phenol inhibitor complexed with Macrophage Migration Inhibitory Factor Deposited 2014-02-12 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 4MT N-[2-(4-hydroxyphenyl)ethyl]thioformamide × 3 SO4 SULFATE ION × 12 CL CHLORIDE ION × 2 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；1.9M ammonium sulfate, 100mM Tris pH 8.0, 200mM NaCl, 4%(v/v) 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.62 Å R-free 0.223
4OYQ (6-isothiocyanatohexyl)benzene inhibitor complexed with Macrophage Migration Inhibitory Factor Deposited 2014-02-12 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 1X2 6-isothiocyanatohexylbenzene × 3 SO4 SULFATE ION × 4 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；1.9 M ammonium sulfate, 100 mM Tris pH 8.0, 200 mM NaCl, 4%(v/v) 2-propanol
Resolution 1.70 Å R-free 0.195
4P01 Crystal Structure Analysis of Macrophage Migration Inhibitory Factor in complex with N-[(4-cyanophenyl)methyl]methanethioamide Deposited 2014-02-19 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 1ZW N-[(4-cyanophenyl)methyl]methanethioamide × 2 IPA ISOPROPYL ALCOHOL × 2 GOL GLYCEROL × 1 CL CHLORIDE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5
Resolution 2.07 Å R-free 0.228
4P0H Crystal Structure Analysis of Macrophage Migration Inhibitory Factor in complex with Dimethylformamide Deposited 2014-02-21 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded DMF DIMETHYLFORMAMIDE × 3 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；2 M ammonium Sulphate, 3% 2-propanol,20 mM Tris.HCl pH 7.5
Resolution 1.93 Å R-free 0.217
4PKK Crystal structure of Macrophage Migration inhibitory factor in complex with furan-2-ylmethyl)imino methanethiol Deposited 2014-05-14 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 31E (Z)-[(furan-2-ylmethyl)imino]methanethiol × 3 GOL GLYCEROL × 4 SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5
Resolution 1.78 Å R-free 0.181
4PKZ Crystal structure of P1M mutant of Macrophage Migration Inhibitory Factor Deposited 2014-05-15 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：P1M Mutation：P1M Mutation：P1M SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5
Resolution 1.90 Å R-free 0.251
4PLU Crystal structure of Macrophage Migration Inhibitory Factor in complex with benzaldehyde Deposited 2014-05-19 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded HBX benzaldehyde × 3 SO4 SULFATE ION × 2 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；2 M ammonium Sulphate, 3% 2-propanol,20 mM Tris.HCl pH 7.5
Resolution 1.63 Å R-free 0.214
4TRF Crystal structure of Macrophage Migration Inhibitory Factor in complex with N-(pyridin-3-ylmethyl)thioformamide Deposited 2014-06-16 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 35J N-(pyridin-3-ylmethyl)thioformamide × 3 SO4 SULFATE ION × 3 GOL GLYCEROL × 2 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；2 M ammonium Sulphate, 3% 2-propanol,20 mM Tris.HCl pH 7.5
Resolution 1.63 Å R-free 0.181
4TRU Crystal structure of Q24A Q25A mutant of human macrophage migration inhibitory factor Deposited 2014-06-17 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Q24A, Q25A Mutation：Q24A, Q25A Mutation：Q24A, Q25A SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 3 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；2 M ammonium Sulphate, 3% 2-propanol,20 mM Tris.HCl pH 7.5
Resolution 1.81 Å R-free 0.191
4WR8 Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-180) Deposited 2014-10-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 9 3TX 4-[4-(quinolin-2-yl)-1H-1,2,3-triazol-1-yl]phenol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.0M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol
Resolution 2.60 Å R-free 0.280
4WR8 Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-180) Deposited 2014-10-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain D 2–115（114 aa）
Chain E 2–115（114 aa）
Chain F 2–115（114 aa）
Not recorded SO4 SULFATE ION × 9 3TX 4-[4-(quinolin-2-yl)-1H-1,2,3-triazol-1-yl]phenol × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.0M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol
Resolution 2.60 Å R-free 0.280
4WR8 Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-180) Deposited 2014-10-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain G 2–115（114 aa）
Chain H 2–115（114 aa）
Chain I 2–115（114 aa）
Not recorded SO4 SULFATE ION × 9 3TX 4-[4-(quinolin-2-yl)-1H-1,2,3-triazol-1-yl]phenol × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.0M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol
Resolution 2.60 Å R-free 0.280
4WR8 Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-180) Deposited 2014-10-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain J 2–115（114 aa）
Chain K 2–115（114 aa）
Chain L 2–115（114 aa）
Not recorded SO4 SULFATE ION × 9 3TX 4-[4-(quinolin-2-yl)-1H-1,2,3-triazol-1-yl]phenol × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.0M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol
Resolution 2.60 Å R-free 0.280
4WR8 Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-180) Deposited 2014-10-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain M 2–115（114 aa）
Chain N 2–115（114 aa）
Chain O 2–115（114 aa）
Not recorded SO4 SULFATE ION × 8 3TX 4-[4-(quinolin-2-yl)-1H-1,2,3-triazol-1-yl]phenol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.0M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol
Resolution 2.60 Å R-free 0.280
4WR8 Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-180) Deposited 2014-10-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 6 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain P 2–115（114 aa）
Chain Q 2–115（114 aa）
Chain R 2–115（114 aa）
Not recorded SO4 SULFATE ION × 9 3TX 4-[4-(quinolin-2-yl)-1H-1,2,3-triazol-1-yl]phenol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.0M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol
Resolution 2.60 Å R-free 0.280
4WRB Macrophage Migration Inhibitory Factor in complex with a biaryltriazole inhibitor (3b-190) Deposited 2014-10-23 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 3TW 4-{4-[6-(2-methoxyethoxy)quinolin-2-yl]-1H-1,2,3-triazol-1-yl}phenol × 1 SO4 SULFATE ION × 6 IPA ISOPROPYL ALCOHOL × 4 GOL GLYCEROL × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.2M ammonium sulfate, 0.1M Tris-HCl pH 7, 3% isopropanol
Resolution 1.81 Å R-free 0.205
4XX7 Crystal structure of M2A mutant of human macrophage migration inhibitory factor Deposited 2015-01-29 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa） Fragment：UNP residues
Chain B 2–115（114 aa） Fragment：UNP residues
Chain C 2–115（114 aa） Fragment：UNP residues
Mutation：M2A Mutation：M2A Mutation：M2A SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；291 K；2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5
Resolution 1.77 Å R-free 0.187
4XX8 Crystal structure of Pro1 deletion mutant of human macrophage migration inhibitory factor Deposited 2015-01-30 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 3–115（113 aa）
Chain B 3–115（113 aa）
Chain C 3–115（113 aa）
Mutation：Pro1 deletion Mutation：Pro1 deletion Mutation：Pro1 deletion SO4 SULFATE ION × 5 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；291 K；2 M ammonium Sulphate, 3% 2-propanol, 20 mM Tris.HCl, pH 7.5
Resolution 1.77 Å R-free 0.188
4Z15 MIF in complex with 3-(2-furylmethyl)-2-thioxo-1,3-thiazolan-4-one Deposited 2015-03-26 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) IPA ISOPROPYL ALCOHOL × 1 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；Tris, ammonium sulfate, isopropanol
Resolution 1.60 Å R-free 0.210
4Z1T MIF in complex with 4-[(4-oxo-2-thioxo-1,3-thiazolan-3-yl)methyl]benzonitrile Deposited 2015-03-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) IPA ISOPROPYL ALCOHOL × 2 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；Tris, ammonium sulfate, isopropanol
Resolution 1.50 Å R-free 0.225
4Z1U MIF in complex with 1-(4-methylphenyl)-3-phenylprop-2-yn-1-one Deposited 2015-03-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) SO4 SULFATE ION × 6 GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；Tris, ammonium sulfate, isopropanol
Resolution 2.05 Å R-free 0.205
4Z1U MIF in complex with 1-(4-methylphenyl)-3-phenylprop-2-yn-1-one Deposited 2015-03-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain D 2–115（114 aa）
Chain E 2–115（114 aa）
Chain F 2–115（114 aa）
Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) Non-standard monomer：Yes (specific site not provided by mmCIF) SO4 SULFATE ION × 9 GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；295 K；Tris, ammonium sulfate, isopropanol
Resolution 2.05 Å R-free 0.205
5B4O Crystal structure of Macrophage Migration Inhibitory Factor in complex with BTZO-14 Deposited 2016-04-07 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa） Fragment：UNP residues 2-115
Chain B 2–115（114 aa） Fragment：UNP residues 2-115
Chain C 2–115（114 aa） Fragment：UNP residues 2-115
Not recorded 6DQ 2-pyridin-3-yl-1,3-benzothiazin-4-one × 4 EDO 1,2-ETHANEDIOL × 1 SO4 SULFATE ION × 9 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 9；293 K；2.4M ammonium sulfate, 0.1M bicine pH 9.0 , 2.4 mM BTZO-14
Resolution 1.37 Å R-free 0.198
5BS9 Crystal structure of N109A mutant of human macrophage migration inhibitory factor Deposited 2015-06-01 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：N109A Mutation：N109A Mutation：N109A SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 6 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.98 Å R-free 0.185
5BSC Crystal structure of K66A mutant of human macrophage migration inhibitory factor Deposited 2015-06-01 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：K66A Mutation：K66A Mutation：K66A IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.89 Å R-free 0.218
5BSI Crystal structure of Y36A mutant of human macrophage migration inhibitory factor Deposited 2015-06-02 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Y36A Mutation：Y36A Mutation：Y36A SO4 SULFATE ION × 3 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 2.00 Å R-free 0.221
5BSI Crystal structure of Y36A mutant of human macrophage migration inhibitory factor Deposited 2015-06-02 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain D 2–115（114 aa）
Chain E 2–115（114 aa）
Chain F 2–115（114 aa）
Mutation：Y36A Mutation：Y36A Mutation：Y36A SO4 SULFATE ION × 3 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 2.00 Å R-free 0.221
5BSI Crystal structure of Y36A mutant of human macrophage migration inhibitory factor Deposited 2015-06-02 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain G 2–115（114 aa）
Mutation：Y36A SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 2.00 Å R-free 0.221
5BSI Crystal structure of Y36A mutant of human macrophage migration inhibitory factor Deposited 2015-06-02 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain J 2–115（114 aa）
Mutation：Y36A SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 2.00 Å R-free 0.221
5BSJ Crystal structure of S63A mutant of human macrophage migration inhibitory factor Deposited 2015-06-02 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：S63A Mutation：S63A Mutation：S63A SO4 SULFATE ION × 4 IPA ISOPROPYL ALCOHOL × 2 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 2.00 Å R-free 0.210
5EIZ Crystal structure of Y99A mutant of human macrophage migration inhibitory factor Deposited 2015-10-30 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Y99A Mutation：Y99A Mutation：Y99A GOL GLYCEROL × 3 SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.96 Å R-free 0.181
5HVS Crystal Structure of Macrophage Migration Inhibitory Factor (MIF) with a Biaryltriazole Inhibitor (3i-305) Deposited 2016-01-28 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 6 65V 3-({2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]quinolin-5-yl}oxy)benzoic acid × 3 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；293.15 K；2.0M ammonium sulfate, 0.1M Tris-HCl pH 8, 3% isopropanol
Resolution 1.75 Å R-free 0.206
5HVT Crystal Structure of Macrophage Migration Inhibitory Factor (MIF) with a Potent Inhibitor (NVS-2) Deposited 2016-01-28 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 6 NVS 7-hydroxy-3-(4-methoxyphenyl)-3,4-dihydro-2H-1,3-benzoxazin-2-one × 3 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.0 M Ammonium Sulfate, 3% isopropanol and 0.1 M Tris pH 7.0
Resolution 1.75 Å R-free 0.203
5HVV Crystal structure of Pro1 deletion and M2A double mutant of Macrophage Migration Inhibitory Factor Deposited 2016-01-28 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 3–115（113 aa） Fragment：UNP residues 3-113
Chain B 3–115（113 aa） Fragment：UNP residues 3-113
Chain C 3–115（113 aa） Fragment：UNP residues 3-113
Mutation：M2A Mutation：M2A Mutation：M2A SO4 SULFATE ION × 1 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.90 Å R-free 0.191
5J7P Macrophage Migration Inhibitory Factor bound to Covalent Inhibitor RDR03785 Deposited 2016-04-06 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 6H1 6-{[4-(trifluoromethyl)phenyl]methyl}-2H-1,3-benzodioxol-5-ol × 3 SO4 SULFATE ION × 7 IPA ISOPROPYL ALCOHOL × 2 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.2 M Ammonium Sulfate, 3% isopropanol and 0.1 M Tris pH 7.0
Resolution 1.85 Å R-free 0.201
5J7Q Macrophage Migration Inhibitory Factor bound to Inhibitor K664 Derivative Deposited 2016-04-06 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 6H2 4-(imidazo[1,2-a]pyridin-2-yl)benzene-1,2-diol × 1 SO4 SULFATE ION × 7 GOL GLYCEROL × 2 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293.15 K；2.4 M Ammonium Sulfate, 3% isopropanol and 0.1 M Tris pH 7.0
Resolution 2.05 Å R-free 0.233
5UMJ Crystal structure of H62A mutant of human macrophage migration inhibitory factor Deposited 2017-01-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：H62A Mutation：H62A Mutation：H62A SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.61 Å R-free 0.179
5UMK Crystal structure of H62Y mutant of human macrophage migration inhibitory factor Deposited 2017-01-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：H62Y Mutation：H62Y Mutation：H62Y SO4 SULFATE ION × 2 IPA ISOPROPYL ALCOHOL × 4 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.73 Å R-free 0.175
5UZY Crystal structure of N97A mutant of human macrophage migration inhibitory factor Deposited 2017-02-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：N97A Mutation：N97A Mutation：N97A SO4 SULFATE ION × 4 IPA ISOPROPYL ALCOHOL × 3 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.71 Å R-free 0.178
5V70 Crystal structure of N102A mutant of human macrophage migration inhibitory factor Deposited 2017-03-17 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：N102A Mutation：N102A Mutation：N102A SO4 SULFATE ION × 5 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.94 Å R-free 0.198
5V73 Crystal structure of N110A mutant of human macrophage migration inhibitory factor Deposited 2017-03-17 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：N110A Mutation：N110A Mutation：N110A SO4 SULFATE ION × 4 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.0 - 8.0
Resolution 1.68 Å R-free 0.175
5XEJ Crystal Structure of Macrophage Migration Inhibitory Factor bound to MTX Deposited 2017-04-05 Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa） Fragment：UNP residues 2-115
Chain B 2–115（114 aa） Fragment：UNP residues 2-115
Chain C 2–115（114 aa） Fragment：UNP residues 2-115
Not recorded SO4 SULFATE ION × 4 6UV (2~{R})-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；298 K；0.1M HEPES(pH7.5), 65% Sat. AS, 2% PEG400
Resolution 2.50 Å R-free 0.227
6B1C Macrophage Migration Inhibitory Factor in complex with a Naphthyridinone Inhibitor (4a) Deposited 2017-09-18 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 4 C9J 2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-7-methyl-1,7-naphthyridin-8(7H)-one × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7；293.15 K；2.6 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7, 3% ISOPROPANOL, 2% DMSO
Resolution 2.16 Å R-free 0.254
6B1K Macrophage Migration Inhibitory Factor in Complex with a Naphthyridinone Inhibitor (3a) Deposited 2017-09-18 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded C9G 2-[1-(4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-7-methyl-1,7-naphthyridin-8(7H)-one × 3 SO4 SULFATE ION × 4 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7.5；293.15 K；2.1 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7.5, 3% ISOPROPANOL, 1.4% DMSO
Resolution 1.17 Å R-free 0.154
6B2C Macrophage Migration Inhibitory Factor in Complex with a Naphthyridinone Inhibitor (4b) Deposited 2017-09-19 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 1 C9Y {2-[1-(3-fluoro-4-hydroxyphenyl)-1H-1,2,3-triazol-4-yl]-8-oxo-1,7-naphthyridin-7(8H)-yl}acetic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7.5；293.15 K；2.1 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7.5, 3% ISOPROPANOL, 2% DMSO
Resolution 2.00 Å R-free 0.222
6BG6 Crystal structure of S111A mutant of human macrophage migration inhibitory factor Deposited 2017-10-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：S111A Mutation：S111A Mutation：S111A SO4 SULFATE ION × 3 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 6 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M Ammonium Sulphate, 3% 2-propanol, 100 mM Tris.HCl, pH 7.5
Resolution 1.52 Å R-free 0.174
6BG7 Crystal structure of G107A mutant of human macrophage migration inhibitory factor Deposited 2017-10-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：G107A Mutation：G107A Mutation：G107A SO4 SULFATE ION × 4 IPA ISOPROPYL ALCOHOL × 3 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 2.54 Å R-free 0.225
6CB5 Macrophage Migration Inhibitory Factor in complex with a Pyrazole Inhibitor (8g) Deposited 2018-02-02 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded EV7 2-[(naphthalen-2-yl)oxy]-5-(1H-pyrazol-4-yl)benzoic acid × 3 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7；293.15 K；2.0 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7.0, 3% ISOPROPANOL
Resolution 1.78 Å R-free 0.212
6CBF Macrophage Migration Inhibitory Factor in Complex with a Pyrazole Inhibitor (6a) Deposited 2018-02-02 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded EWD 2-phenoxy-5-(1H-pyrazol-4-yl)benzoic acid × 2 SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；2.4M ammonium sulfate, 3% isopropanol, 0.1M Tris pH 6.5
Resolution 2.30 Å R-free 0.282
6CBG Macrophage Migration Inhibitory Factor in Complex with a Pyrazole Inhibitor (5) Deposited 2018-02-02 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 6 GOL GLYCEROL × 9 EWG 3-(1H-pyrazol-4-yl)benzoic acid × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；293.15 K；2.4M ammonium sulfate, 3% isopropanol, 0.1M Tris pH 7
Resolution 2.00 Å R-free 0.205
6CBH Macrophage Migration Inhibitory Factor in Complex with a Pyrazole Inhibitor (8m) Deposited 2018-02-02 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 6 IPA ISOPROPYL ALCOHOL × 2 GOL GLYCEROL × 2 EWJ 5-(3-fluoro-1H-pyrazol-4-yl)-2-[(naphthalen-2-yl)oxy]benzoic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2.4M ammonium sulfate, 3% isopropanol, 0.1M Tris pH 7
Resolution 2.00 Å R-free 0.214
6FVE Macrophage Migration Inhibitory Factor (MIF) with Covalently Bound FITC Deposited 2018-03-02 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded 6B9 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-5-[(E)-(sulfanylmethylidene)amino]benzoic acid × 3 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7；298 K；Ammonium Sulfate, 0.1M Hepes pH 7.0
Resolution 1.41 Å R-free 0.189
6FVH Macrophage Migration Inhibitory Factor (MIF) with Covalently Bound PITC Deposited 2018-03-02 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 6 0FI N-phenylthioformamide × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；Ammonium Sulfate, Hepes
Resolution 1.40 Å R-free 0.166
6OY8 Crystal structure of Y99G mutant of human macrophage migration inhibitory factor Deposited 2019-05-14 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Y99G Mutation：Y99G Mutation：Y99G SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 2 GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.53 Å R-free 0.175
6OYB Crystal structure of H62G mutant of human macrophage migration inhibitory factor Deposited 2019-05-14 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：H62G Mutation：H62G Mutation：H62G SO4 SULFATE ION × 4 GOL GLYCEROL × 5 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.53 Å R-free 0.161
6OYE Crystal structure of Y99F mutant of human macrophage migration inhibitory factor Deposited 2019-05-14 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Y99F Mutation：Y99F Mutation：Y99F GOL GLYCEROL × 4 SO4 SULFATE ION × 3 IPA ISOPROPYL ALCOHOL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.53 Å R-free 0.168
6OYG Crystal structure of H62F mutant of human macrophage migration inhibitory factor Deposited 2019-05-14 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：H62F Mutation：H62F Mutation：H62F SO4 SULFATE ION × 3 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.55 Å R-free 0.154
6PEG MIF with a allosteric inhibitor Deposited 2019-06-20 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain D 2–115（114 aa）
Chain E 2–115（114 aa）
Chain F 2–115（114 aa）
Not recorded ACT ACETATE ION × 4 GOL GLYCEROL × 2 SO4 SULFATE ION × 3 4FQ 4-amino-5-hydroxy-6-[(E)-(3-{[3-(2-methylpropanoyl)pyrazolo[1,5-a]pyridin-2-yl]methyl}phenyl)diazenyl]naphthalene-1,3-disulfonic acid × 1 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；298 K；100microMolar 4048, 2M Ammonium sulfate, 4% isopropanol, 50 mM Tris pH 8.0, 12.5% Glycerol, 50mM sodium acetate Protein 100mg/ml MIF in 50mM citrate pH 5, 50microMolar 4048
Resolution 2.00 Å R-free 0.188
7E45 Crystal structure of compound 7 bound to MIF Deposited 2021-02-10 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 13 HWO (2R)-7-[(2R,3R,4R,5S,6S)-6-(hydroxymethyl)-3-[(2R,3R,4R,5R,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4,5-bis(oxidanyl)oxan-2-yl]oxy-2-(4-methoxy-3-oxidanyl-phenyl)-5-oxidanyl-2,3-dihydrochromen-4-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2.0 M ammonium sulfate, 0.1 M Tris pH 7.0, 3% isopropanol
Resolution 1.43 Å R-free 0.186
7E47 Crystal structure of compound 6 bound to MIF Deposited 2021-02-10 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 7 HWR (2S,3R,4R,5R,6R)-2-[(2S,3R,4S,5R,6S)-6-(hydroxymethyl)-2-[[(2R,4R)-2-(4-hydroxyphenyl)-4,5-bis(oxidanyl)-3,4-dihydro-2H-chromen-7-yl]oxy]-4,5-bis(oxidanyl)oxan-3-yl]oxy-6-methyl-oxane-3,4,5-triol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2.0M ammonium sulfate, 3% isopropanol
Resolution 1.38 Å R-free 0.179
7E49 Crystal structure of MIF bound to compound10 Deposited 2021-02-11 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 8 MYC 3,5,7-TRIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；293 K；2.0M ammonium sulfate, 3% isopropanol
Resolution 1.57 Å R-free 0.235
7E4A Crystal structure of MIF bound to compound 13 Deposited 2021-02-11 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 11 HWL Flavoxate × 2 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；310 K；2.0M ammonium sulfate
Resolution 1.48 Å R-free 0.207
7E4B Crystal structure of MIF bound to compound 5 Deposited 2021-02-11 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 4 MRI 2-[2,4-bis(oxidanyl)phenyl]-3,5,7-tris(oxidanyl)chromen-4-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；310 K；2.0M ammonium, 3% isopropanol
Resolution 1.77 Å R-free 0.232
7E4C Crystal structure of MIF bound to compound11 Deposited 2021-02-11 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 13 SO4 SULFATE ION × 4 GBJ 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H,8H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol × 1 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；310 K；2.0M ammonium sulfate, 3% isopropanol
Resolution 1.64 Å R-free 0.191
7EDQ MIF complex to compound7 Deposited 2021-03-16 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded HFC 6,7-bis(oxidanyl)chromen-2-one × 1 CL CHLORIDE ION × 8 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；290 K；2.0M Ammonium sulfate
Resolution 1.27 Å R-free 0.190
7EE8 The crystal structure of MIF bound to compound D5 Deposited 2021-03-17 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded CL CHLORIDE ION × 9 7Y8 3-[(2R)-2-azanyl-1-oxidanyl-propyl]phenol × 1 J23 3-[(2S)-2-azanyl-1-oxidanyl-propyl]phenol × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；310 K；2.0M Ammonium sulfate, pH7.50
Resolution 1.22 Å R-free 0.242
7KQX MIF Y99C homotrimeric mutant Deposited 2020-11-18 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：Y99C Mutation：Y99C Mutation：Y99C SO4 SULFATE ION × 3 GOL GLYCEROL × 15 IPA ISOPROPYL ALCOHOL × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.60 Å R-free 0.180
7XTX High resolution crystal structure of human macrophage migration inhibitory factor in complex with methotrexate Deposited 2022-05-18 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 4 EDO 1,2-ETHANEDIOL × 11 IPA ISOPROPYL ALCOHOL × 3 MT1 N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM-6-YL)METHYL](METHYL)AMINO}BENZOYL)-L-GLUTAMIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；283 K；2.0 M Ammonium sulfate 0.1 M Tris-HCl (pH 8.0) 4 % isopropanol
Resolution 1.28 Å R-free 0.188
7XVX Neutron crystal structure of human macrophage migration inhibitory factor Deposited 2022-05-25 Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded No recorded non-water small molecule Experimental method not declared
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；283 K；0.49 M Monosodium phosphate, 0.91 M Dipotassium phosphate
Resolution not provided
8CA0 Macrophage inhibitory factor (MIF) in complex with small molecule PAV174 Deposited 2023-01-24 Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded VIU 1-ethyl-9-methyl-3,7-dipyrrolidin-1-yl-phenothiazine × 1 SOLUTION NMR
NMR measurement conditions pH 7.2；298 K；Ionic strength (raw mmCIF value) 20；Pressure 1
NMR sample composition 1.0 mM [U-13C; U-15N] MIF, 1.0 mM PAV, 100% D2O | 100% D2O
Resolution not provided
8IMR Structure of ligand-free human macrophage migration inhibitory factor Deposited 2023-03-07 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded SO4 SULFATE ION × 2 EDO 1,2-ETHANEDIOL × 6 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；283 K；2.0 M Ammonium sulfate 0.1 M Tris-HCl (pH 8.0) 4 % Isopropanol
Resolution 1.30 Å R-free 0.217
8SON Crystal structure of macrophage migration inhibitory factor in complex with N-[3-(Trifluoromethyl)phenyl]-3-(2-chloroanilino)-2-cyano-3-thioxopropanamide Deposited 2023-04-28 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded GOL GLYCEROL × 3 SO4 SULFATE ION × 3 30Y (2R)-3-[(2-chlorophenyl)amino]-2-cyano-3-thioxo-N-[3-(trifluoromethyl)phenyl]propanamide × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；20 mM Tris.HCl, pH 7.5, 2 M ammonium sulfate, and 3% 2-propanol
Resolution 1.63 Å R-free 0.199
8SPN Crystal structure of macrophage migration inhibitory factor in complex with T614 Deposited 2023-05-03 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Mutation：No Mutation：No Mutation：No SO4 SULFATE ION × 2 IPA ISOPROPYL ALCOHOL × 1 GOL GLYCEROL × 1 7TN Iguratimod × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5
Resolution 1.73 Å R-free 0.202
8TT8 Joint Xray/Neutron structure of Macrophage Migration Inhibitory Factor (MIF) Bound to 4-hydroxyphenylpyruvate at room temperature Deposited 2023-08-13 Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded ENO 3-(4-HYDROXY-PHENYL)PYRUVIC ACID × 2 IPA ISOPROPYL ALCOHOL × 1 EN1 (2E)-2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid × 1 Experimental method not declared
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7.4；295 K；Protein: 1 mM MIF, 10 mM deuterated HPP, 20 mM NaCl in 20 mM Tris (pH 7.4) mixed 1:1 with reservoir containing 2M (NH4)2SO4, 1% isopropanol in 100 mM Tris (pH 7.4).
Resolution not provided
9BNQ N-(4-(isothiocyanatomethyl)phenyl)methanesulfonamide complexed with Macrophage Migration Inhibitory Factor Deposited 2024-05-02 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded A1AQU N-{[4-(methanesulfonamido)phenyl]methyl}methanethioamide × 3 SO4 SULFATE ION × 5 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；289.15 K；0.2 uL 11 mg/mL MIF (100 mM Tris-HCl pH 8.0, 200 mM NaCl) were mixed with 0.2 uL of reservoir solution. Sitting drop reservoir contained 33 uL of 2.1 M Ammonium sulfate, 0.1 M Tris pH 7.5, 3% Isopropanol and <5mM N-(4-(isothiocyanatomethyl)phenyl)methanesulfonamide (10% DMSO final). Crystal was frozen in a solution of ~25% Glycerol, 75% reservoir
Resolution 1.09 Å R-free 0.154
9BNR 4-(2-isothiocyanatoethyl)benzenesulfonamide complexed with Macrophage Migration Inhibitory Factor Deposited 2024-05-02 Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–115（114 aa）
Chain B 2–115（114 aa）
Chain C 2–115（114 aa）
Not recorded A1AQT N-[2-(4-sulfamoylphenyl)ethyl]methanethioamide × 3 SO4 SULFATE ION × 9 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7；289.15 K；0.2 uL 11 mg/mL MIF (100 mM Tris-HCl pH 8.0, 200 mM NaCl) were mixed with 0.2 uL of reservoir solution. Sitting drop reservoir contained 33 uL of 2.0 M Ammonium sulfate, 0.1 M HEPES pH 7.0, 3% Isopropanol and <5mM 4-(2-isothiocyanatoethyl)benzenesulfonamide (10% DMSO final). Crystal was frozen in a solution of ~25% Glycerol, 75% reservoir
Resolution 1.53 Å R-free 0.178
9JIT Macrophage migration inhibitory factor S61H/Y100H mutant (MIF(S61H/Y100H)) Deposited 2024-09-12 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–115（115 aa）
Chain B 1–115（115 aa）
Chain C 1–115（115 aa）
Mutation：S61H/Y100H Mutation：S61H/Y100H Mutation：S61H/Y100H SO4 SULFATE ION × 4 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2.0M ammonium sulfate, 20mM Tris-HCl buffer (pH 7.5), 3% isopropanol
Resolution 1.08 Å R-free 0.155
9JIV Macrophage migration inhibitory factor Y100H mutant (MIF(Y100H)) Deposited 2024-09-12 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–115（115 aa）
Chain B 1–115（115 aa）
Chain C 1–115（115 aa）
Mutation：Y100H Mutation：Y100H Mutation：Y100H SO4 SULFATE ION × 4 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2.0M ammonium sulfate, 20mM Tris-HCl buffer (pH 7.5), 3% isopropanol
Resolution 1.25 Å R-free 0.152
9JIY Macrophage migration inhibitory factor S61H/Y100H mutant complexed with three Zinc ions (Zn3-MIF(S61H/Y100H)-L) Deposited 2024-09-12 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–115（115 aa）
Chain B 1–115（115 aa）
Chain C 1–115（115 aa）
Mutation：S61H/Y100H Mutation：S61H/Y100H Mutation：S61H/Y100H ZN ZINC ION × 3 CO3 CARBONATE ION × 1 SO4 SULFATE ION × 5 GOL GLYCEROL × 4 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；293 K；2.0M ammonium sulfate, 20mM Tris-HCl buffer (pH 7.5), 3% isopropanol
Resolution 1.20 Å R-free 0.174
9JIZ Macrophage migration inhibitory factor S61H/Y100H mutant complexed with three Zinc ions (Zn3-MIF(S61H/Y100H)) Deposited 2024-09-12 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–115（115 aa）
Chain B 1–115（115 aa）
Chain C 1–115（115 aa）
Mutation：S61H/Y100H Mutation：S61H/Y100H Mutation：S61H/Y100H ZN ZINC ION × 3 CO3 CARBONATE ION × 1 SO4 SULFATE ION × 4 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2.0M ammonium sulfate, 20mM Tris-HCl buffer (pH 7.5), 3% isopropanol
Resolution 1.30 Å R-free 0.167
9JJ0 Macrophage migration inhibitory factor Y100H mutant complexed with three Zinc ions (Zn3-MIF(Y100H)) Deposited 2024-09-12 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–115（115 aa）
Chain B 1–115（115 aa）
Chain C 1–115（115 aa）
Mutation：Y100H Mutation：Y100H Mutation：Y100H ZN ZINC ION × 3 CL CHLORIDE ION × 3 CO3 CARBONATE ION × 1 SO4 SULFATE ION × 3 GOL GLYCEROL × 3 IPA ISOPROPYL ALCOHOL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7.5；293 K；2.0M ammonium sulfate, 20mM Tris-HCl buffer (pH 7.5), 3% isopropanol
Resolution 1.25 Å R-free 0.146

117 other PDB entries and 132 assemblies. Open the comparison page and filter oligomeric states

View Construct and Data Evidence
UniProt name MIF_HUMAN
Isoform —
PDB entities 1
Chains and sequence ranges Author chain A； PDBConstruct 1–114； UniProt 2–115 Author chain B； PDBConstruct 1–114； UniProt 2–115 Author chain C； PDBConstruct 1–114； UniProt 2–115

The page prioritizes protein identity, the current assembly, associated components, oligomeric state and cross-PDB links. Chain mapping and sequence ranges are retained as data evidence. Internal IDs, import timestamps and assembly operation expressions are maintenance fields and are not shown here.

SAXS scattering curve SAXS Profile

SAXS profile for 8tt9

P(r) Distance Distribution P(r) Distribution

P(r) distribution for 8tt9
Download Download
▼

2. Structure Basics 2. Structure Basics

Entry ID entry_id8tt9
Deposition date deposition_date2023-08-13
Structure title titleX-ray structure of Macrophage Migration Inhibitory Factor (MIF) Covalently Bound to 4-hydroxyphenylpyruvate (HPP)
Keywords keywordsMACROPHAGE MIGRATION INHIBITORY FACTOR, CYTOKINE; CYTOKINE
Experimental Method methodX-RAY DIFFRACTION
▼

3. SAXS Parameters (CRYSOL theoretical calculation) 3. SAXS Parameters (CRYSOL)

Radius of gyration Rg (Guinier) rg_guinier19.86 Å
Radius of gyration Rg (electron density) rg_electron18.65 Å
Forward intensity I(0) i022988900.00
Molecular weight molecular_weight37134.0 kDa
Excluded volume excluded_volume46548 ų
Envelope volume envelope_volume51662 ų
Hydration-shell volume shell_volume22305 ų
Envelope diameter envelope_diameter56.9 Å
Shell Rg shell_rg25.76 Å
Envelope Rg envelope_rg18.70 Å
Shape Rg shape_rg18.67 Å
Total Rg total_rg19.50 Å
Total atoms total_atoms2610
Residues n_residues342
Spherical-harmonic order n_harmonics20
q range q_range— – 0.5000 Å−1
Data points n_points101
Shell type shell_typedirectional
Solvent electron density solvent_density0.3340 e/ų
Shell contrast contrast_shell0.0300 e/ų
CRYSOL version crysol_version4.1.3
▼

4. P(r) Distance Distribution (GNOM inversion) 4. P(r) Analysis (GNOM)

Maximum dimension Dmax dmax59.6 Å
Rg (real space) rg_real19.66 Å
Rg uncertainty (real space) rg_real_error0.34 Å
I(0) (real space) i0_real2.2990e+07
I(0) uncertainty (real space) i0_real_error2.7060e+05
Rg (reciprocal space) rg_reciprocal19.69 Å
I(0) (reciprocal space) i0_reciprocal22990000.0000
Solution quality estimate total_estimate0.8948
Solution quality rating solution_quality GOOD a GOOD solution
P(r) peaks n_peaks2
Primary peak position r_peak_primary26.9 Å
Skewness Skewness skewness-0.005
Kurtosis Kurtosis kurtosis-0.559
Angular range angular_range— – 0.4000 Å−1
Current regularization parameter α current_alpha0.0000
Highest regularization parameter α highest_alpha4873000.0000
Real-space data points n_real_points72
GNOM version gnom_version4.1.3
Quality Criteria quality_criteria AN1: 0.000; Oscil: 0.888; Stabil: 0.997; Sysdev: 1.000; Positv: 1.000; Valcen: 0.974; Smooth: 0.998
▶

5. Crystallography and Experiment 5. Crystallography & Experiment

▶

6. Entities and Polymers Entities & Polymers (4)

▶

8. Citations (1)

▶

9. Files and Curves (10)